Biodesix Inc.

NASDAQ: BDSX · Real-Time Price · USD
0.29
-0.01 (-4.26%)
At close: Jun 09, 2025, 3:59 PM

Biodesix Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
74.46M 71.32M 65.56M 60.9M 54.85M 49.09M 44.03M 41.64M 40.72M 38.21M 35.83M 31.25M 32.19M 54.51M 74.31M 76.97M 69.33M
Cost of Revenue
16.1M 15.57M 14.61M 13.65M 13.02M 13.01M 12.94M 13.35M 14.09M 14.15M 13.34M 12.43M 15.54M 30.52M 42.68M 43.85M 38.63M
Gross Profit
58.36M 55.75M 50.96M 47.25M 41.83M 36.08M 31.09M 28.3M 26.63M 24.06M 22.49M 18.82M 16.65M 23.99M 31.63M 33.13M 30.69M
Operating Income
-32.55M -34.36M -34.56M -33.14M -35.9M -41.3M -48.34M -51.78M -52.48M -50.51M -48.3M -50.78M -49.74M -40.94M -31.92M -25.07M -20.1M
Interest Income
n/a n/a n/a 2.39M 4.82M 7.21M 9.76M 10.41M 7.98M 5.59M 3.04M n/a n/a n/a 9K 9K 9K
Pretax Income
-40.42M -42.93M -43.82M -44.51M -47.06M -52.15M -63.34M -66.09M -68.56M -65.45M -58.39M -56.21M -51.78M -43.16M -34.41M -31.74M -28.61M
Net Income
-40.42M -42.93M -43.82M -44.51M -47.06M -50.56M -68.21M -74.05M -76.51M -76.19M -62.69M -57.41M -52.99M -43.16M -34.41M -31.74M -28.61M
Selling & General & Admin
80.34M 80.45M 76.48M 71.96M 68.95M 67.39M 67.76M 67.38M 65.96M 61.46M 58.39M 56.89M 53.08M 50.52M 49.02M 43.3M 38.7M
Research & Development
10.39M 9.56M 9.03M 8.43M 8.78M 9.99M 11.66M 12.7M 13.15M 13.1M 12.39M 12.71M 12.67M 12.79M 13.04M 12.46M 11.24M
Other Expenses
-211K -348K -449K -447K -59K 6K -1K -1K 98K 109K 104K 2.82M 2.08M 2.07M 2.12M -1.51M -734K
Operating Expenses
90.91M 90.11M 85.52M 80.39M 77.73M 77.38M 79.43M 80.08M 79.11M 74.56M 70.78M 69.6M 65.75M 63.31M 62.06M 55.75M 49.94M
Interest Expense
7.41M 8.26M 8.84M 9.18M 9.67M 9.54M 9.76M 10.41M 9.33M 8.07M 7.02M 5.53M 4.99M 4.51M 3.72M 4.83M 6.8M
Selling & Marketing Expenses
n/a n/a -18.99M -18.99M -18.99M n/a 35.62M 50.73M 65.96M 61.46M 58.39M 56.89M 53.08M 50.52M 49.02M 43.3M 38.7M
Cost & Expenses
107.01M 105.69M 100.12M 94.04M 90.75M 90.39M 92.37M 93.42M 93.2M 88.72M 84.12M 82.03M 81.29M 93.82M 104.74M 99.6M 88.58M
Income Tax Expense
-1.28M n/a -1.95M 433.72K 2.86M n/a 9.68M 10.38M 9.4M 12.19M -1.78M -3.32M -3.95M -4.51M 3.02M 3.23M 5.33M
Shares Outstanding (Basic)
146.55M 129.67M 146.3M 127.17M 97.17M 92.33M 79.71M 78.51M 77.77M 57.8M 40.45M 39.24M 31.07M 27.06M 28.05M 27.73M 26.6M
Shares Outstanding (Diluted)
146.55M 129.67M 146.3M 127.17M 97.17M 92.33M 79.71M 78.51M 77.77M 57.8M 40.45M 39.24M 31.07M 27.06M 28.05M 27.73M 26.6M
EPS (Basic)
-0.3 -0.36 -0.39 -0.46 -0.55 -0.63 -0.99 -1.27 -1.5 -1.82 -1.85 -1.84 -1.85 -1.57 -1.25 -1.17 -1.07
EPS (Diluted)
-0.3 -0.36 -0.39 -0.46 -0.55 -0.63 -0.99 -1.27 -1.5 -1.82 -1.85 -1.84 -1.85 -1.57 -1.25 -1.17 -1.07
EBITDA
-27.46M -29.22M -29.62M -30.14M -32.1M -37.86M -49.25M -51.69M -55.76M -53.78M -47.82M -47.22M -43.5M -35.55M -27.71M -23.95M -18.86M
EBIT
-33M -34.67M -34.98M -35.33M -37.38M -42.61M -53.59M -55.69M -59.24M -57.38M -51.37M -50.68M -46.79M -38.65M -30.69M -26.91M -21.81M
Depreciation & Amortization
5.54M 5.46M 5.36M 5.18M 5.28M 4.75M 4.34M 3.99M 3.47M 3.6M 3.55M 3.46M 3.29M 3.18M 3.05M 3.04M 3.02M